UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of Report (Date of Earliest Event Reported): December 14,
2005
(November
15, 2005)
|
|
ISORAY,
INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
Minnesota
(State
or other jurisdiction
of
incorporation)
|
000-14247
(Commission
File
Number)
|
41-1458152
(IRS
Employer
Identification
No.)
|
350
Hills Street, Suite 106, Richland, Washington 99354
(Address
of principal executive offices) (Zip Code)
(509)
375-1202
(Registrant's
telephone number)
ITEM 4.01
Changes in Registrant's Certifying Accountant
The
Company’s Board of Directors engaged DeCoria, Maichel & Teague, P.S., the
independent auditor for the Company's wholly-owned subsidiary, to be its
new
independent auditor effective November 15, 2005, which was also the effective
date of S.W. Hatfield, CPA’s dismissal as the Company’s certifying accountant by
the Board.
Except
for an expression of doubt about our ability to continue as a going concern,
S.W. Hatfield's
audit
reports on the Company’s financial statements as of June 30, 2005 and September
30, 2004 did not contain an adverse opinion or disclaimer of opinion, nor
were
they qualified or modified as to uncertainty, audit scope or accounting
principles.
During
the two fiscal years ended June 30, 2005 and September 30, 2004, and through
November 15, 2005 there were no disagreements with S.W. Hatfield on any matter
of accounting principles or practices, financial statement disclosure, or
auditing scope or procedures, which disagreements, if not resolved to the
satisfaction of S.W. Hatfield would have caused it to make a reference to
the
subject matter of the disagreements in connection with its report; and there
were no reportable events as described in Item 304(a)(1)(iv)(B) of Regulation
S-B promulgated by the Securities and Exchange Commission (the “SEC”) pursuant
to the Securities Exchange Act of 1934, as amended.
The
Company provided S.W. Hatfield with a copy of this disclosure and requested
that
S.W. Hatfield furnish the Company with a letter addressed to the SEC stating
whether it agrees with the foregoing statements by the Company and, if not,
stating the respects in which it does not agree. A copy of the letter from
S.W.
Hatfield is filed herewith as Exhibit 16.1.
During
the Company’s two most recent fiscal years and through November 15, 2005, the
Company did not consult DeCoria, Maichel & Teague with respect to the
application of accounting principles to a specified transaction, either
completed or proposed, or the type of audit opinion that might be rendered
on
the Company’s financial statements, or any other matters or reportable events
listed in Item 304(a)(2) of Regulation S-B. However, IsoRay Medical, Inc.,
the
Company's wholly-owned subsidiary, has consulted with DeCoria, Maichel &
Teague, its independent auditor, during these time periods solely in connection
with IsoRay Medical's financial statements.
ITEM
9.01 Exhibits
|
16.1
|
Letter
from S.W. Hatfield, CPA to the SEC dated December 13,
2005.
|
SIGNATURES
In
accordance with the requirements of the Exchange Act, the Registrant caused
this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Dated:
December 13, 2005
|
|
|
|
IsoRay,
Inc., a Minnesota corporation |
|
|
|
|
By: |
/s/ Michael
K. Dunlop |
|
Michael
K. Dunlop, CFO
|
|
|